Rainer Wessel
Advisory Board
cytena
Germany
Biography
Rainer Wessel has more than 20 years of experience in the pharmaceutical and life science industry. He served for 5 years as Director Cluster-Management at the Rhine-Main Leading Edge Immunology Cluster Ci3 and 9 years as Chief Executive Officer of biotechnology companies Ganymed Pharmaceuticals AG (Mainz) and Axxima Pharmaceuticals AG (Munich). Before, he served as International Head of IP & Licensing at Qiagen GmbH (Hilden). Dr. Wessel was trained in Intellectual Property at the patent department of Boehringer Ingelheim (BI) GmbH (Ingelheim) after a research trainee position at BI KK (Osaka, Japan). The BI Fonds and DAAD fellow received his PhD from the University of Constance in 1992. Among other functions, Dr. Wessel is Supervisory Board member of the International Council of the Life Sciences (ICLS, Washington, DC), a member of the Development Board of the German Cancer Research Center (DKFZ, Heidelberg), the International Strategy Board of Oncotyrol (Innsbruck) and the International Institute of Strategic Studies (IISS, London, UK). From 2004 – 2015 he served as a Board Member of the German biotech industry organization BIO Deutschland (Berlin).
Research Interest
Pharmaceutical and life science
